𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Muscarinic agonists and antagonists in the treatment of Alzheimer's disease

✍ Scribed by W Greenlee; J Clader; T Asberom; S McCombie; J Ford; H Guzik; J Kozlowski; S Li; C Liu; D Lowe; S Vice; H Zhao; G Zhou; W Billard; H Binch; R Crosby; R Duffy; J Lachowicz; V Coffin; R Watkins; V Ruperto; C Strader; L Taylor; K Cox


Book ID
114018960
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
206 KB
Volume
56
Category
Article
ISSN
0014-827X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Xanomeline: A selective muscarinic agoni
✍ Frank P. Bymaster; Celia A. Whitesitt; Harlan E. Shannon; Neil DeLapp; John S. W πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 147 KB πŸ‘ 3 views

Xanomeline is a novel muscarinic receptor agonist relatively devoid of parasympathomimetic side effects. Xanomeline had high affinity for muscarinic receptors and much lower affinity for a variety of other neuronal receptors in radioligand binding assays. Functional studies in cell lines transfected